In order to improve the inspection abilities and guarantee the inspection quality and efficiency, the first training course of drugs registration (drugs research and manufacture) for senior inspectors was held in Nanjing from May 25 to May 26, 2021.

This training received great supports from Jiangsu Medical Products Administration. Jiang Wei, vice director of Jiangsu Medical Products Administration attended this training and gave a speech. This training mainly focused on the new requirements and challenge inspection work facing after the implementation of the new Measures for the Administration of Drug Registration . 70 national inspectors from 29 provinces attended this course and discussed in groups. Through the training, the principle of dealing with common problems in inspection is further clarified. Dong Jiangping, deputy director of CFDI, emphasized drug registration inspection work ideas under the new regulatory framework in 2021.

This training combined theoretical training with on-site practice. After the training, the inspectors participated in the on-site inspection work of the registration application.